These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 9808679

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhanced antinociception of the model opioid peptide [D-penicillamine] enkephalin by P-glycoprotein modulation.
    Chen C, Pollack GM.
    Pharm Res; 1999 Feb; 16(2):296-301. PubMed ID: 10100317
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Distribution and analgesia of [3H][D-Pen2, D-Pen5]enkephalin and two halogenated analogs after intravenous administration.
    Weber SJ, Greene DL, Sharma SD, Yamamura HI, Kramer TH, Burks TF, Hruby VJ, Hersh LB, Davis TP.
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1109-17. PubMed ID: 1762065
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability.
    Greene DL, Hau VS, Abbruscato TJ, Bartosz H, Misicka A, Lipkowski AW, Hom S, Gillespie TJ, Hruby VJ, Davis TP.
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1366-75. PubMed ID: 8667199
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pluronic p85 block copolymer enhances opioid peptide analgesia.
    Witt KA, Huber JD, Egleton RD, Davis TP.
    J Pharmacol Exp Ther; 2002 Nov; 303(2):760-7. PubMed ID: 12388663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier.
    Milane A, Fernandez C, Vautier S, Bensimon G, Meininger V, Farinotti R.
    J Neurochem; 2007 Oct; 103(1):164-73. PubMed ID: 17635670
    [Abstract] [Full Text] [Related]

  • 17. Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin.
    Zong J, Pollack GM.
    J Pharmacol Exp Ther; 2003 Aug; 306(2):556-62. PubMed ID: 12721332
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier.
    Choo EF, Kurnik D, Muszkat M, Ohkubo T, Shay SD, Higginbotham JN, Glaeser H, Kim RB, Wood AJ, Wilkinson GR.
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1012-8. PubMed ID: 16537797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.